Symbol="TGTX"
AssetType="Common Stock"
Name="TG Therapeutics Inc"
Description="TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York."
CIK="1001316"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1567164000"
EBITDA="-162664000"
PERatio="None"
PEGRatio="0"
BookValue="0.198"
DividendPerShare="0"
DividendYield="0"
EPS="-1.24"
RevenuePerShareTTM="0.063"
ProfitMargin="0"
OperatingMarginTTM="-19.01"
ReturnOnAssetsTTM="-0.407"
ReturnOnEquityTTM="-1.704"
RevenueTTM="8572000"
GrossProfitTTM="2520000"
DilutedEPSTTM="-1.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.871"
AnalystTargetPrice="31.44"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="249.27"
PriceToBookRatio="10.88"
EVToRevenue="198.82"
EVToEBITDA="-4.349"
Beta="2.047"
num_52WeekHigh="35.67"
num_52WeekLow="4.86"
num_50DayMovingAverage="24.21"
num_200DayMovingAverage="17.03"
SharesOutstanding="149396000"
DividendDate="None"
ExDividendDate="None"
symbol="TGTX"
open="11.88"
high="12.00"
low="9.58"
price="10.49"
volume="37963752.00"
latest_trading_day="2023-08-01"
previous_close="20.69"
change="-10.20"
change_percent="-49.2992%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="11"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="89"
Volume_recent_avg="4403316"
Change_recent_avg="0.01"
Delta_recent_avg="1.5"
Variance_recent_avg="0.75"
Change_ratio_recent_avg="-0.19"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="89"
Aroon_momentum_negative="11"
image_negative_thumbnail_id_1="134"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0042.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="693"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0015.jpeg"
image_positive_thumbnail_id_2="996"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
